🇺🇸 Carboxymethylcellulose in United States

2,640 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 428 reports (16.21%)
  2. Macular Degeneration — 366 reports (13.86%)
  3. Off Label Use — 317 reports (12.01%)
  4. Nausea — 302 reports (11.44%)
  5. Pain — 228 reports (8.64%)
  6. Pyrexia — 217 reports (8.22%)
  7. Weight Decreased — 216 reports (8.18%)
  8. Malaise — 195 reports (7.39%)
  9. Infusion Related Reaction — 189 reports (7.16%)
  10. Therapeutic Product Effect Incomplete — 182 reports (6.89%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Carboxymethylcellulose approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Carboxymethylcellulose in United States?

University of Campinas, Brazil is the originator. The local marketing authorisation holder may differ — check the official source linked above.